Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer

Autor: Pointreau Y, Bensadoun RJ, Bera G, Sire C, Ruffier A, Janoray G, Calais G, Bollet M, Pinel B, Braniste V, Amores X

Publikováno v: Patient Preference and Adherence, Vol Volume 14, Pp 859-868 (2020)

Yoann Pointreau,1 Rene-Jean Bensadoun,2 Guillaume Bera,3 Christian Sire,3 Amandine Ruffier,4 Guillaume Janoray,4,5 Gilles Calais,4 Marc Bollet,6 Baptiste Pinel,7 Viorica Braniste,8 Xavier Amores8 1Radiotherapy Department, Interregional Cancer Institu

Externí odkaz: https://doaj.org/article/71fdfb3fc31543b887d9d9b6f204c48e

Neogene-Quaternary slow coastal uplift of Western Europe through the perspective of sequences of strandlines from the Cotentin Peninsula (Normandy, France)

Autor: Pedoja, K., Jara-Muñoz, J., De Gelder, G., Robertson, J., Meschis, M., Fernandez-Blanco, D., Nexer, M., Poprawski, Y., Dugué, O., Delcaillau, B., Bessin, P., Benabdelouahed, M., Authemayou, C., Husson, L., Regard, V., Menier, D., Pinel, B.

Publikováno v: In Geomorphology 15 February 2018 303:338-356

A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma.

Autor: Betancor YZ; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Ferreiro-Pantín M; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Anido-Herranz U; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Fuentes-Losada M; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., León-Mateos L; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., García-Acuña SM; Department of Pathology, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Vaamonde-Rodríguez V; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., García-Pinel B; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Cebey-López V; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Villaverde-Viaño R; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Lombardía-Rodríguez H; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Kotrulev M; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Fernández-Díaz N; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Gomez-Tourino I; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Fernández-Baltar C; Department of Urology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., García-González J; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Tubio JMC; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., López-López R; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Ruiz-Bañobre J; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Apr 10; Vol. 15, pp. 1374728. Date of Electronic Publication: 2024 Apr 10 (Print Publication: 2024).

Radioterapia dei cancri otorinolaringoiatrici

Autor: Bensadoun, R.-J., Pinel, B.

Publikováno v: In EMC – Otorinolaringoiatria June 2013 12(2):1-12

Candidose oropharyngée et radiothérapie

Autor: Pinel, B., Cassou-Mounat, T., Bensadoun, R.-J.

Publikováno v: In Cancer / Radiothérapie May 2012 16(3):222-229